Literature DB >> 15924263

The NF-kappaB signaling pathway in human genetic diseases.

Gilles Courtois1.   

Abstract

The nuclear factor-kappaB (NF-kappaB) signaling pathway plays a key role in inflammation, immune response, cell growth control and protection against apoptosis. Recently, it has been associated with several distinct genetic diseases that exhibit a large spectrum of dysfunction, such as skin inflammation, perturbed skin appendage development and immunodeficiencies. In this review, a summary of the pathophysiological consequences of impaired NF-kappaB activation in humans is provided with respect to the functions of the molecules which are mutated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924263     DOI: 10.1007/s00018-005-5031-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  18 in total

1.  Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.

Authors:  Yanhua Liang; Rosemarie E Seymour; John P Sundberg
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

2.  Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.

Authors:  Ladan Dawoody Nejad; Alireza Biglari; Tiziana Annese; Domenico Ribatti
Journal:  Oncol Lett       Date:  2017-03-31       Impact factor: 2.967

3.  Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14.

Authors:  Jennie Lugassy; Peter Itin; Akemi Ishida-Yamamoto; Kristen Holland; Susan Huson; Dan Geiger; Hans Christian Hennies; Margarita Indelman; Dani Bercovich; Jouni Uitto; Reuven Bergman; John A McGrath; Gabriele Richard; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2006-08-25       Impact factor: 11.025

Review 4.  An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities.

Authors:  Francesca Annunziata; Cecilia Pinna; Sabrina Dallavalle; Lucia Tamborini; Andrea Pinto
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

5.  A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy.

Authors:  Lena F Schimke; Nikolaus Rieber; Stacey Rylaarsdam; Otávio Cabral-Marques; Nicholas Hubbard; Anne Puel; Laura Kallmann; Stephanie Anover Sombke; Gundula Notheis; Hans-Peter Schwarz; Birgit Kammer; Tomas Hökfelt; Reinald Repp; Capucine Picard; Jean-Laurent Casanova; Bernd H Belohradsky; Michael H Albert; Hans D Ochs; Ellen D Renner; Troy R Torgerson
Journal:  J Clin Immunol       Date:  2013-05-25       Impact factor: 8.317

6.  Colitis and cancer: a tale of inflammatory cells and their cytokines.

Authors:  Ezra Burstein; Eric R Fearon
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin.

Authors:  M Amigó; M Payá; S De Rosa; M C Terencio
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

8.  Pigment epithelium-derived factor is retinal ganglion cell neuroprotective and axogenic after optic nerve crush injury.

Authors:  Vasanthy Vigneswara; Martin Berry; Ann Logan; Zubair Ahmed
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-12       Impact factor: 4.799

9.  The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.

Authors:  Maciej T Nogalski; Jagat P Podduturi; Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

10.  Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC.

Authors:  Qiwei Zhang; Xiaomin Zhang; Hao Wu; Donald Seto; Hao-Jie Zhang; Zhiwei Chen; Chengsong Wan; Bo-Jian Zheng
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.